{"id":"placebo-for-pravastatin","safety":{"commonSideEffects":[{"rate":null,"effect":"Placebo effect (symptom improvement unrelated to active drug)"},{"rate":null,"effect":"Adverse events attributable to expectation or underlying disease progression"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo is an inert substance used as a control in clinical trials to establish baseline efficacy and safety of an active drug. Any observed effects are attributed to the placebo effect—psychological and physiological responses to the expectation of treatment rather than the substance itself. In this context, it serves as the comparator arm in pravastatin efficacy and safety studies.","oneSentence":"A placebo contains no active pharmaceutical ingredient and produces no direct pharmacological effect.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:36:10.675Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control arm in pravastatin clinical trials (hyperlipidemia, cardiovascular disease prevention)"}]},"trialDetails":[{"nctId":"NCT07098975","phase":"PHASE2","title":"Statin Intervention for Severe Early-Onset Placental Insufficiency. (STATIN-PRE Trial)","status":"RECRUITING","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2026-01-14","conditions":"Preeclampsia (PE), Intrauterine Growth Restriction (IUGR), Placental Insufficiency","enrollment":154},{"nctId":"NCT03273413","phase":"PHASE4","title":"Statin Therapy in Patients With Early Stage ADPKD","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2017-08-31","conditions":"ADPKD, Autosomal Dominant Polycystic Kidney","enrollment":150},{"nctId":"NCT01717586","phase":"PHASE1","title":"Pravastatin for Prevention of Preeclampsia","status":"COMPLETED","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2012-08","conditions":"Preeclampsia","enrollment":48},{"nctId":"NCT03510884","phase":"PHASE3","title":"An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia","status":"COMPLETED","sponsor":"Sanofi","startDate":"2018-05-31","conditions":"Hypercholesterolaemia","enrollment":153},{"nctId":"NCT02871687","phase":"PHASE1","title":"Effect of Statin Use on Aldosterone Secretion","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2016-04","conditions":"Healthy Subjects","enrollment":103},{"nctId":"NCT01047501","phase":"PHASE3","title":"Effect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels (≥ 200 and < 500 mg/dL)","status":"COMPLETED","sponsor":"Amarin Pharma Inc.","startDate":"2009-12","conditions":"Hypertriglyceridemia","enrollment":702},{"nctId":"NCT01047683","phase":"PHASE3","title":"Efficacy and Safety of AMR101 (Ethyl Icosapentate) in Patients With Fasting Triglyceride (Tg) Levels ≥ 500 and ≤ 2000 mg/dL","status":"COMPLETED","sponsor":"Amarin Pharma Inc.","startDate":"2009-12","conditions":"Hypertriglyceridemia","enrollment":229},{"nctId":"NCT01492361","phase":"PHASE3","title":"A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High-Risk Patients With Hypertriglyceridemia and on Statin","status":"COMPLETED","sponsor":"Amarin Pharma Inc.","startDate":"2011-11","conditions":"Cardiovascular Diseases","enrollment":8179},{"nctId":"NCT00697203","phase":"PHASE2","title":"A Study to Assess the Effect of RO4607381 in Patients With Relatively Low Levels of High Density Lipoprotein-Cholesterol (HDL-C)","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2005-07","conditions":"Dyslipidemia","enrollment":292},{"nctId":"NCT01890967","phase":"PHASE2","title":"A Study of LY3015014 in Participants With High Cholesterol","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2013-06","conditions":"Hypercholesterolemia","enrollment":527},{"nctId":"NCT02754739","phase":"PHASE4","title":"Effect of Pravastatin in the Subjects With Prediabetes or Early Diabetes","status":"COMPLETED","sponsor":"Samsung Medical Center","startDate":"2014-04-15","conditions":"Diabetes Mellitus, Prediabetic State","enrollment":44},{"nctId":"NCT00982189","phase":"NA","title":"Cardiovascular Prevention for Persons With HIV","status":"COMPLETED","sponsor":"Hennepin Healthcare Research Institute","startDate":"2009-09","conditions":"HIV Infection, Cardiovascular Disease Risk","enrollment":37},{"nctId":"NCT00127218","phase":"PHASE3","title":"High-Density Lipoprotein (HDL) Cholesterol Increased Plaque Stabilization in the Elderly","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2003-09","conditions":"Atherosclerosis, Cardiovascular Disease","enrollment":145},{"nctId":"NCT03073018","phase":"PHASE3","title":"Prevention of Renal and Vascular Endstage Disease Intervention Trial","status":"COMPLETED","sponsor":"University Medical Center Groningen","startDate":"1998-04","conditions":"Microalbuminuria, Cardiovascular Diseases, Renal Disease","enrollment":864},{"nctId":"NCT00850460","phase":"PHASE4","title":"Quality of Life in Patients With Statin-Associated Myopathy","status":"TERMINATED","sponsor":"Rockefeller University","startDate":"2009-02","conditions":"Statin Adverse Reaction","enrollment":14},{"nctId":"NCT02107898","phase":"PHASE3","title":"Efficacy and Safety Evaluation of Alirocumab in Patients With Heterozygous Familial Hypercholesterolemia or High Cardiovascular Risk Patients With Hypercholesterolemia on Lipid Modifying Therapy (ODYSSEY JAPAN)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2014-03","conditions":"Hypercholesterolemia","enrollment":216},{"nctId":"NCT00532311","phase":"PHASE3","title":"Efficacy of Lapaquistat Acetate Co-Administered With Statins in Subjects With Hypercholesterolemia","status":"TERMINATED","sponsor":"Takeda","startDate":"2007-07","conditions":"Hypercholesterolemia","enrollment":411},{"nctId":"NCT00755352","phase":"PHASE4","title":"A Study to Determine the Effect of WelChol Tablets on Cholesterol in Patients Who Have Been Taking Pravastatin for at Least 4 Weeks.","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2002-11","conditions":"Hypercholesterolemia","enrollment":67},{"nctId":"NCT00433498","phase":"PHASE3","title":"Etoposide and Cisplatin or Carboplatin as First-Line Chemotherapy With or Without Pravastatin in Treating Patients With Small Cell Lung Cancer","status":"COMPLETED","sponsor":"University College, London","startDate":"2007-01","conditions":"Lung Cancer","enrollment":846},{"nctId":"NCT01082588","phase":"PHASE4","title":"Effects of Pravastatin on Cholesterol, Inflammation and Cognition in Schizophrenia","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2010-06","conditions":"Schizophrenia, Schizoaffective Disorders, Schizophreniform Disorders","enrollment":60},{"nctId":"NCT00330980","phase":"PHASE4","title":"Effects of Statin Medications on Mental Processes, Behavior, and Serotonin Levels","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2000-04","conditions":"Dyslipidemias","enrollment":1000}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":630,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Placebo (for Pravastatin)","genericName":"Placebo (for Pravastatin)","companyName":"Samsung Medical Center","companyId":"samsung-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A placebo contains no active pharmaceutical ingredient and produces no direct pharmacological effect. Used for Control arm in pravastatin clinical trials (hyperlipidemia, cardiovascular disease prevention).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}